These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 13209536)

  • 1. Studies on a transplantable chicken tumor, RPL-12 lymphoma. II. Mechanism of regression following infection with an oncolytic virus.
    LOVE R; SHARPLESS GR
    Cancer Res; 1954 Oct; 14(9):640-7. PubMed ID: 13209536
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on a transplantable chicken tumor (RPL-12 lymphoma). III. Cytological changes during virus-induced oncolysis.
    LOVE R; SHARPLESS GR
    Cancer Res; 1954 Nov; 14(10):758-67. PubMed ID: 13209556
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on a transplantable chicken lymphoma (RPL-12) I. Pathological changes following transplantation of the tumor.
    LOVE R; SHARPLESS GR
    Cancer Res; 1953 Dec; 13(12):869-75. PubMed ID: 13116126
    [No Abstract]   [Full Text] [Related]  

  • 4. Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application.
    Apostolidis L; Schirrmacher V; Fournier P
    Int J Oncol; 2007 Nov; 31(5):1009-19. PubMed ID: 17912426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
    Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes.
    Pühler F; Willuda J; Puhlmann J; Mumberg D; Römer-Oberdörfer A; Beier R
    Gene Ther; 2008 Mar; 15(5):371-83. PubMed ID: 18200068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.
    Anderson BD; Nakamura T; Russell SJ; Peng KW
    Cancer Res; 2004 Jul; 64(14):4919-26. PubMed ID: 15256464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant peripheral nerve sheath tumors with high and low Ras-GTP are permissive for oncolytic herpes simplex virus mutants.
    Mahller YY; Rangwala F; Ratner N; Cripe TP
    Pediatr Blood Cancer; 2006 Jun; 46(7):745-54. PubMed ID: 16124003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
    Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
    Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses.
    Reddy PS; Ganesh S; Yu DC
    Clin Cancer Res; 2006 May; 12(9):2869-78. PubMed ID: 16675583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virus.
    Fu X; Tao L; Cai R; Prigge J; Zhang X
    Mol Ther; 2006 May; 13(5):882-90. PubMed ID: 16569513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model.
    Li H; Dutuor A; Fu X; Zhang X
    J Gene Med; 2007 Mar; 9(3):161-9. PubMed ID: 17266169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of mice to multiple inoculations of a transplantable tumor.
    BARRETT MK; HANSEN WH
    J Natl Cancer Inst; 1954 Dec; 15(3):411-20. PubMed ID: 13233896
    [No Abstract]   [Full Text] [Related]  

  • 17. The potential of oncolytic virus therapy for pancreatic cancer.
    Kasuya H; Takeda S; Nomoto S; Nakao A
    Cancer Gene Ther; 2005 Sep; 12(9):725-36. PubMed ID: 15818382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increase in host specificity of a transplantable spindle-cell tumor in mice.
    STRONG LC
    Cancer Res; 1953 Dec; 13(12):876-9. PubMed ID: 13116127
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors.
    Yaacov B; Eliahoo E; Lazar I; Ben-Shlomo M; Greenbaum I; Panet A; Zakay-Rones Z
    Cancer Gene Ther; 2008 Dec; 15(12):795-807. PubMed ID: 18535620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide allows for in vivo dose reduction of a potent oncolytic virus.
    Kambara H; Saeki Y; Chiocca EA
    Cancer Res; 2005 Dec; 65(24):11255-8. PubMed ID: 16357128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.